The Cancer Letter

Inside information on cancer research and drug development

Vol.
34
No.
5
May 27, 2011May 27, 2011
Free
DOWNLOAD THE PDF

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

Revlimid Maintenance Therapy Delayed Progression by 90%

Drug Effectiveness Weakens After Three Years, Study Says

Nexavar Improves PFS In HER-2 Negative Breast Cancer

Xgeva Significantly Increases Bone Metastasis-Free Survival

U.S. Patients Use More Chemotherapy, Less Emergency Care than Canadians

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

Clinical Trials Approved By NCI CTEP Last Month

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

Abbott PCR Test For HCV Load Sensitive to Within 12 IU/mL

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account